When delivering the Parkinson’s disease-associated GBA1 gene, BI-hTFR1 significantly enhanced glucocerebrosidase activity in both brain tissue and cerebrospinal fluid, highlighting its potential for human CNS gene therapy applications. Here, GBA1 is linked to Parkinson disease.